Nadiya Ishnazarova, PhD, is an Associate at M Ventures Biotechnology team covering Healthcare and Life Sciences investments. Nadiya joined M Ventures in 2021. Previously, Nadiya was a Project Manager in the Health & Life Sciences practice of global strategy consulting firm Oliver Wyman. She focused on the strategy and corporate transformation for corporate healthcare clients, health systems, providers, pharma and digital health clients in EMEA, Asia Pacific and Emerging Markets. Nadiya also supported M&A deals in the Healthcare and Life Science space on pre-transaction assessments of sources of value and risk. Nadiya received her Ph.D. in Biochemistry from the University of Oxford and her dissertation was focused on investigating the molecular mechanisms of recombination-dependent replication. She gained her B.Sc. in Organic Chemistry, and double M.Sc. in Enzymology and Nanobiomaterials and Nanobiotechnology from Lomonosov Moscow State University. Nadiya is based in Amsterdam at the M Ventures head office.